334 related articles for article (PubMed ID: 36521673)
21. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
[TBL] [Abstract][Full Text] [Related]
22. MRI-guided liposomes for targeted tandem chemotherapy and therapeutic response prediction.
Ren L; Chen S; Li H; Zhang Z; Zhong J; Liu M; Zhou X
Acta Biomater; 2016 Apr; 35():260-8. PubMed ID: 26873364
[TBL] [Abstract][Full Text] [Related]
23. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.
Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC
Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736
[TBL] [Abstract][Full Text] [Related]
24. Nanoformulations for therapy of pancreatic and liver cancers.
de Souza PC; Ranjan A; Towner RA
Nanomedicine (Lond); 2015 May; 10(9):1515-34. PubMed ID: 25996122
[TBL] [Abstract][Full Text] [Related]
25. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
Bhattacharya S; Saindane D; Prajapati BG
Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
27. Advances in the Application of Liposomal Nanosystems in Anticancer Therapy.
Xiao D; Zhou R
Curr Stem Cell Res Ther; 2021; 16(1):14-22. PubMed ID: 32324519
[TBL] [Abstract][Full Text] [Related]
28. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
29. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
30. Dual-targeting nanocarrier system based on thermosensitive liposomes and gold nanorods for cancer thermo-chemotherapy.
Yu M; Guo F; Tan F; Li N
J Control Release; 2015 Oct; 215():91-100. PubMed ID: 26256259
[TBL] [Abstract][Full Text] [Related]
31. Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers.
Das M; Huang L
J Pharmacol Exp Ther; 2019 Sep; 370(3):647-656. PubMed ID: 30541917
[TBL] [Abstract][Full Text] [Related]
32. Integrin α
Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S
Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597
[TBL] [Abstract][Full Text] [Related]
33. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.
Dicheva BM; Koning GA
Expert Opin Drug Deliv; 2014 Jan; 11(1):83-100. PubMed ID: 24320104
[TBL] [Abstract][Full Text] [Related]
34. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
35. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
Nikolova MP; Kumar EM; Chavali MS
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
[TBL] [Abstract][Full Text] [Related]
36. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
37. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Alavi M; Hamidi M
Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
[TBL] [Abstract][Full Text] [Related]
38. Safety of novel liposomal drugs for cancer treatment: Advances and prospects.
He K; Tang M
Chem Biol Interact; 2018 Nov; 295():13-19. PubMed ID: 28919304
[TBL] [Abstract][Full Text] [Related]
39. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in liposome formulations for breast cancer therapeutics.
Yang B; Song BP; Shankar S; Guller A; Deng W
Cell Mol Life Sci; 2021 Jul; 78(13):5225-5243. PubMed ID: 33974093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
